🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder

RecruitingNAAges 9 Years - 15 YearsAllUniversity of Calgary
NCT04532190 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Diagnosis of ADHD 2. 9-15 years old 3. IQ greater than 80 4. English fluency (to enable consent/assent) 5. If on medication, must have been on the same type and dosage for at least 3 months. Exclusion Criteria: 1. Diagnosis of mania, psychosis, or bipolar disorder 2. Impediments to TMS or MRI (i.e. metal implants in body) 3. Prior electroconvulsive therapy or vagus nerve stimulation 4. Diagnosis of Autism Spectrum Disorder.
💊

What it tests

  • rTMS
📍

Where

1 site
Alberta Children's Hospital
Calgary, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy